These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 22280188

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Market watch: pricing strategies for emerging markets.
    Lineberry N, Snyder E, Gunda S.
    Nat Rev Drug Discov; 2011 Aug 01; 10(8):567. PubMed ID: 21804586
    [No Abstract] [Full Text] [Related]

  • 6. Convergence of decision rules for value-based pricing of new innovative drugs.
    Gandjour A.
    Expert Rev Pharmacoecon Outcomes Res; 2015 Apr 01; 15(2):209-13. PubMed ID: 25327543
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. How New Zealand has contained expenditure on drugs.
    Cumming J, Mays N, Daubé J.
    BMJ; 2010 May 18; 340():c2441. PubMed ID: 20483927
    [No Abstract] [Full Text] [Related]

  • 9. Mega-mergers in the pharmaceutical industry. In whose interests?
    Po AL.
    Pharmacoeconomics; 1998 Oct 18; 14(4):349-55. PubMed ID: 10344903
    [Abstract] [Full Text] [Related]

  • 10. Reference pricing of pharmaceuticals.
    Brekke KR, Königbauer I, Straume OR.
    J Health Econ; 2007 May 01; 26(3):613-42. PubMed ID: 17188769
    [Abstract] [Full Text] [Related]

  • 11. Pharmaceutical Pricing and Market Access Outlook Europe 2010-HealthNetwork Communications' fourth annual conference. 24-25 March 2010, London, UK.
    Ogbighele E.
    IDrugs; 2010 May 01; 13(5):317-20. PubMed ID: 20432188
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Medicines pricing singled out.
    Buchanan E.
    S Afr Med J; 2004 May 01; 94(5):334. PubMed ID: 15211941
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pharmaceutical reference prices. How do they work in practice?
    Dickson M, Redwood H.
    Pharmacoeconomics; 1998 Nov 01; 14(5):471-9. PubMed ID: 10344913
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The 340B Drug Pricing Program: an opportunity for savings, if covered entities such as disproportionate share hospitals and federally qualified health centers know how to interpret the regulations.
    Werling K, Abraham S, Strelec J.
    J Health Care Finance; 2007 Nov 01; 34(2):57-70. PubMed ID: 18972994
    [No Abstract] [Full Text] [Related]

  • 20. Costing drug development.
    Nat Rev Drug Discov; 2003 Apr 01; 2(4):247. PubMed ID: 12680358
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.